BREAKING
OpenEvidence Eyes $20B Valuation
0
M
Potential raise
0
B
Valuation
Valuation Doubling Each Round
Series B Jul25
3.5
Series C Oct25
6
Series D Jan26
12
New round
20
0
%
US physicians
0
M
Consultations
0
M
Americans treated
Praised, But Not Without Limits
Strengths
●
Evidence-based, cited answers
●
Fast for broad questions
●
Ties to NEJM, JAMA, Cochrane
Concerns
●
14-46% accuracy on specialist cases
●
Metadata errors noted
●
Limited outcome studies
AI Moves Into Daily Clinical Care
AI NEWS BLITZ
OpenEvidence is weighing a new raise that could value it at roughly twenty billion dollars.